1) Using monoclonal antibodies prepared against MD B cells to detect a cell marker unique to MS patients. 2) We have conducted an open clinical trial of 20 patients with D pencilliamine for one year. The study is completed and results are being analyzed. 3) HTLV probes of MS brain tissue by PCR.
Showing the most recent 10 out of 461 publications